Publication

[ORAL SURVEILLANCE: what has changed in the risk assessment of JAK inhibitors?].

Journal Paper/Review - Aug 12, 2022

Units
PubMed
Doi
Contact

Citation
Rubbert-Roth A. [ORAL SURVEILLANCE: what has changed in the risk assessment of JAK inhibitors?]. Z Rheumatol 2022; 81:780-781.
Type
Journal Paper/Review (Deutsch)
Journal
Z Rheumatol 2022; 81
Publication Date
Aug 12, 2022
Issn Electronic
1435-1250
Pages
780-781
Brief description/objective